Trial
NCT04914676
Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete Remission
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Florida
Collaborators
—
Condition
Acute Myeloid Leukemia
Intervention
Cytarabine
Why stopped
PI decision to close study early due to limited data due to accrual goal not being met
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-16